For example, when selecting patients with adenocarcinoma and smoking >20 pack-years, 15 of the 38 patients with EGFR mutations (39%) would be missed, whereas 13 of the 62 patients without EGFR mutations (21%) would be mistakenly included. The gene discussed is EGFR; the disease is adenocarcinoma.